FibroGen, Inc. (KYNB)
NASDAQ · Healthcare
FibroGen, Inc. Cash on Hand 2020–2025
FibroGen, Inc. annual cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- FibroGen, Inc. cash on hand as of December 31, 2025: 47.9M, a 5.17% decrease year-over-year.
- FibroGen, Inc. cash on hand for 2025 were 47.9M, a 5.17% decrease from 2024.
- FibroGen, Inc. cash on hand for 2024 were 50.5M, a 55.60% decrease from 2023.
- FibroGen, Inc. cash on hand for 2023 were 113.7M, a 26.98% decrease from 2022.
- FibroGen, Inc. cash on hand for 2022 were 155.7M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| FibroGen, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $48 |
| 2024 | $50 |
| 2023 | $114 |
| 2022 | $156 |
| 2021 | $171 |
| 2020 | $678 |
FibroGen, Inc. Cash on Hand — FAQ
FibroGen, Inc. (KYNB) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KYNB's cash on hand history?
The chart and table above show FibroGen, Inc.'s cash on hand by year and by quarter, including the growth rate.